Crescent Biopharma, Inc. (CBIO)

Augmedix Statistics

Total Valuation

CBIO has a market cap or net worth of $172.55 million. The enterprise value is $175.26 million.

Market Cap	172.55M
Enterprise Value	175.26M

Important Dates

The last earnings date was Thursday, July 31, 2025, before market open.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

CBIO has 13.89 million shares outstanding.

Current Share Class	13.89M
Shares Outstanding	13.89M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.84%
Owned by Institutions (%)	10.37%
Float	4.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.62

Current Ratio	3.62
Quick Ratio	3.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.18

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-264.45%
Revenue Per Employee	n/a
Profits Per Employee	-$11.91M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	139,937

Short Selling Information

The latest short interest is 89,172, so 0.64% of the outstanding shares have been sold short.

Short Interest	89,172
Short Previous Month	33,892
Short % of Shares Out	0.64%
Short % of Float	1.93%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.76M
Pretax Income	n/a
Net Income	-71.47M
EBITDA	n/a
EBIT	-68.76M
Earnings Per Share (EPS)	-$13.45

Balance Sheet

The company has $34.77 million in cash and $37.48 million in debt, giving a net cash position of -$2.72 million or -$0.20 per share.

Cash & Cash Equivalents	34.77M
Total Debt	37.48M
Net Cash	-2.72M
Net Cash Per Share	-$0.20
Equity (Book Value)	-11.48M
Book Value Per Share	-2.20
Working Capital	25.19M

Cash Flow

Operating Cash Flow	-25.08M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-41.42%
FCF Yield	n/a

Analyst Forecast

The average price target for CBIO is $25.67, which is 106.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.67
Price Target Difference	106.68%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1